SouthState Corp’s bluebird bio BLUE Stock Holding History

SouthState Corp’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2	Closed	-$10	–	1623
2025 Q1	$10	Buy	+2	New	+$12	﹤0.01%	1700

Other funds holding BLUE

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SouthState Corp's BLUE Position: Q2 2025 in Review

SouthState Corp sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 2 shares — an estimated $10 sold.

SouthState Corp first reported a position in BLUE in Q1 2025 and held it in 1 quarter. The position peaked at $10 in Q1 2025. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

SouthState Corp reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
SouthState Corp sold 2 bluebird bio shares in Q2 2025, an estimated $10.
SouthState Corp first reported a position in bluebird bio in Q1 2025 and held it in 1 quarter.
SouthState Corp's bluebird bio position peaked at $10 in Q1 2025.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on SouthState Corp's 13F filing for Q2 2025, filed 6 Aug 2025.